Synergy CHC Corp.(SNYR) - 2025 Q3 - Quarterly Results

Financial Performance - Revenue for Q3 2025 was $8.0 million, a 12.4% increase from $7.1 million in Q3 2024[6] - Income from operations rose to $1.28 million, a 21.8% increase compared to $1.05 million in Q3 2024[7] - Adjusted EBITDA for Q3 2025 was $1.52 million, a 13.4% increase from $1.34 million in Q3 2024[9] - Total revenue for Q3 2025 was $8,010,112, a 12.4% increase from $7,126,333 in Q3 2024[22] - Gross profit for the nine months ended September 30, 2025, was $18,083,441, compared to $17,141,106 for the same period in 2024, reflecting a 5.5% increase[22] - Net income after tax for the nine months ended September 30, 2025, was $2,474,827, up from $2,019,309 in 2024, representing a 22.6% increase[22] - Comprehensive income for the nine months ended September 30, 2025, was $2,486,689, compared to $2,127,657 in 2024, reflecting a 16.9% increase[22] Profitability Metrics - Gross margin improved to 70.9% in Q3 2025, up from 67.2% in Q3 2024, driven by a favorable product mix[6] - Net income decreased to $125.3 thousand in Q3 2025, down from $783.6 thousand in Q3 2024[8] - Operating expenses for Q3 2025 totaled $4,400,806, an increase of 17.7% from $3,739,557 in Q3 2024[22] - Interest expense for the nine months ended September 30, 2025, was $4,352,840, compared to $2,559,454 in 2024, indicating a 70.0% increase[22] Cash and Liabilities - As of September 30, 2025, cash and cash equivalents increased to approximately $1.0 million from $687.9 thousand at the end of 2024[10] - Cash and restricted cash at the end of the period was $1,106,489, compared to $359,375 at the end of the same period in 2024[24] - Net cash used in operating activities for the nine months ended September 30, 2025, was $(3,209,149), compared to $(1,377,479) in 2024[24] - The company reduced outstanding liabilities by $3.3 million during the third quarter[5] - Proceeds from issuing common stock amounted to $3,880,462 during the nine months ended September 30, 2025[24] Strategic Initiatives - Synergy completed a $4.4 million public offering in August 2025, enhancing working capital for growth initiatives[2] - Synergy appointed former Costco executive Teresa Thompson to the Board of Directors to strengthen retail expertise[5] - FOCUSfactor was named the 1 Pharmacist Recommended OTC Memory Supplement for 2025-2026, highlighting brand leadership[5] Other Financial Adjustments - The company reported a foreign currency translation adjustment loss of $(26,077) for Q3 2025[22]